Actively Recruiting

Age: 18Years +
All Genders
NCT07112391

Pressure-Volume Loop Assessment in Valvular Heart Disease

Led by Nantes University Hospital · Updated on 2025-09-16

70

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

Sponsors

N

Nantes University Hospital

Lead Sponsor

F

Fédération Française de Cardiologie

Collaborating Sponsor

AI-Summary

What this Trial Is About

The VHD PV loop study intends to assess invasive right ventricular to pulmonary artery (RV-PA) coupling in patients with valvular heart disease (VHD). Invasive RV-PA coupling is measured by using conductance catheters, the gold standard assessment for ventricular physiology. Several non-invasive parameters have been reported as surrogates for this complex physiological entity, but none of them has been tested against the gold-standard in this population. Based on this, our main objective is to assess the correlation of imaging derived RV-PA coupling in comparison to the invasive measurement.

CONDITIONS

Official Title

Pressure-Volume Loop Assessment in Valvular Heart Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (≥ 18 years old)
  • Patients with severe structural heart disease meeting at least one of the following: heart failure with moderate-to-severe or severe secondary mitral regurgitation
  • At least severe tricuspid regurgitation
  • Significant pulmonary valve stenosis and/or regurgitation
Not Eligible

You will not qualify if you...

  • Patients under legal guardianship or protection
  • Pregnant or breastfeeding women
  • Vulnerable individuals such as persons deprived of liberty or adults under legal protection
  • Contraindications to right heart catheterization including known proximal venous occlusion of the superior or inferior vena cava territory
  • Presence of a mobile mass in the right heart chambers
  • Significant tricuspid stenosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU of NANTES

Nantes, Loire Atlantique, France, 44000

Actively Recruiting

Loading map...

Research Team

R

Robin LE RUZ, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here